{{Rsnum
|rsid=2051090
|Gene=DCLK1
|Chromosome=13
|position=35880056
|Orientation=minus
|GMAF=0.3756
|Gene_s=DCLK1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.0 | 51.3 | 17.7
| HCB | 56.2 | 38.7 | 5.1
| JPT | 58.9 | 34.8 | 6.2
| YRI | 17.0 | 53.7 | 29.3
| ASW | 26.3 | 54.4 | 19.3
| CHB | 56.2 | 38.7 | 5.1
| CHD | 53.2 | 34.9 | 11.9
| GIH | 52.5 | 38.6 | 8.9
| LWK | 40.9 | 46.4 | 12.7
| MEX | 36.2 | 48.3 | 15.5
| MKK | 62.8 | 30.1 | 7.1
| TSI | 46.1 | 45.1 | 8.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535911
  |Trait=Non-alcoholic fatty liver disease
  |Title=Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.
  |RiskAllele=G
  |Pval=7E-6
  |OR=1.19
  |ORtxt=[0.88-1.62]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}